Clinical Nutrition Market size valued $40.36 billion in 2021 and expected to reach $57.48 billion in 2028 at a CAGR of 8.6% during forecast period 2022-2028. The nutrition of patients in the healthcare industry is referred to as clinical nutrition. Clinical refers to the treatment of outpatients as well as inpatients at clinics and hospitals in this context. Its goal is to help patients maintain a good energy balance while also giving essential nutrients such protein, vitamins, and minerals. Clinical nutrition has several advantages, including its effectiveness in treating type 1 and type 2 diabetes and its ability to help people live better at any age. Outwardly, clinical nutrition items are given to people who are unable to absorb particular nutrients. The market for clinical nutrition is propelling owing to the growing geriatric population who are highly prone to the major health issues related to the metabolic disorders & loss of appetite. Increase in initiatives taken by the governments, Malnutrition, rise in junk foods intake, poverty, lack in awareness are the factors that are fuelling the growth of clinical nutrition market growth. However, strict government regulations, low reimbursement policies, volatility of the market, patient compliance complexities are the factors hampering the market growth.
In April 2012, Nestle acquired Pfizer Nutrition to increase its position in infant nutrition market globally
In March 2014, Perrigo Company plc and KanPak LLC entered into partnership for manufacturing adult nutritional drinks
In April 2016, Perrigo Company plc, launched Glucerna aseptic nutritional shake for diabetic people
In July 2017, Perrigo Company plc received U.S. FDA approval of AB rated ANDA referencing DermOtic Oil Ear Drops